{"id":"https://openalex.org/W7115166314","doi":"https://doi.org/10.18609/cgti.2025.053","title":"Next-gen cell therapy manufacturing: leveraging flexibility and automation for success","display_name":"Next-gen cell therapy manufacturing: leveraging flexibility and automation for success","publication_year":2025,"publication_date":"2025-05-01","ids":{"openalex":"https://openalex.org/W7115166314","doi":"https://doi.org/10.18609/cgti.2025.053"},"language":"en","primary_location":{"id":"doi:10.18609/cgti.2025.053","doi":"https://doi.org/10.18609/cgti.2025.053","is_oa":true,"landing_page_url":"https://doi.org/10.18609/cgti.2025.053","pdf_url":null,"source":{"id":"https://openalex.org/S4210198480","display_name":"Cell and Gene Therapy Insights","issn_l":"2059-7800","issn":["2059-7800","2397-0545"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell and Gene Therapy Insights","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.18609/cgti.2025.053","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"David Shaw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":[],"is_corresponding":false,"raw_author_name":"David Shaw","raw_affiliation_strings":["Pharma Technical Cell and Gene Therapy, Genentech, Inc., San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Technical Cell and Gene Therapy, Genentech, Inc., San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Fred Parietti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fred Parietti","raw_affiliation_strings":["Multiply Labs, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multiply Labs, San Francisco, CA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Carl Dargitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142480","display_name":"Thermo Fisher Scientific (United States)","ror":"https://ror.org/03x1ewr52","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142480"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carl Dargitz","raw_affiliation_strings":["Thermo Fisher Scientific, Carlsbad, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thermo Fisher Scientific, Carlsbad, CA, USA","institution_ids":["https://openalex.org/I4210142480"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.4626691,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"11","issue":"4","first_page":"439\u2013451","last_page":"439\u2013451"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8500999808311462,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8500999808311462,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.04529999941587448,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11741","display_name":"Flexible and Reconfigurable Manufacturing Systems","score":0.023499999195337296,"subfield":{"id":"https://openalex.org/subfields/2209","display_name":"Industrial and Manufacturing Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cell-therapy-manufacturing","display_name":"cell therapy manufacturing","score":0.9990000128746033},{"id":"https://openalex.org/keywords/automation","display_name":"automation","score":0.6729999780654907},{"id":"https://openalex.org/keywords/production-capacity","display_name":"production capacity","score":0.8080000281333923},{"id":"https://openalex.org/keywords/patient-access","display_name":"patient access","score":0.7850000262260437},{"id":"https://openalex.org/keywords/cell-and-gene-therapy","display_name":"cell and gene therapy","score":0.8159999847412109},{"id":"https://openalex.org/keywords/biopharmaceutical-manufacturing","display_name":"biopharmaceutical manufacturing","score":0.6520000100135803},{"id":"https://openalex.org/keywords/production-flexibility","display_name":"production flexibility","score":0.6499999761581421}],"concepts":[{"id":"https://openalex.org/C115901376","wikidata":"https://www.wikidata.org/wiki/Q184199","display_name":"Automation","level":2,"score":0.833299994468689},{"id":"https://openalex.org/C2780598303","wikidata":"https://www.wikidata.org/wiki/Q65921492","display_name":"Flexibility (engineering)","level":2,"score":0.7441999912261963},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4490000009536743},{"id":"https://openalex.org/C21457203","wikidata":"https://www.wikidata.org/wiki/Q4056293","display_name":"Process automation system","level":3,"score":0.39100000262260437},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.37070000171661377},{"id":"https://openalex.org/C117671659","wikidata":"https://www.wikidata.org/wiki/Q11049265","display_name":"Manufacturing engineering","level":1,"score":0.35760000348091125},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.33980000019073486},{"id":"https://openalex.org/C10882517","wikidata":"https://www.wikidata.org/wiki/Q15268054","display_name":"Cell therapy","level":3,"score":0.3361999988555908},{"id":"https://openalex.org/C201995342","wikidata":"https://www.wikidata.org/wiki/Q682496","display_name":"Systems engineering","level":1,"score":0.3190000057220459},{"id":"https://openalex.org/C195094911","wikidata":"https://www.wikidata.org/wiki/Q14167904","display_name":"Process management","level":1,"score":0.3093999922275543},{"id":"https://openalex.org/C64260653","wikidata":"https://www.wikidata.org/wiki/Q1194864","display_name":"Electronic design automation","level":2,"score":0.29919999837875366},{"id":"https://openalex.org/C207267971","wikidata":"https://www.wikidata.org/wiki/Q120208","display_name":"Emerging technologies","level":2,"score":0.2678999900817871},{"id":"https://openalex.org/C110354214","wikidata":"https://www.wikidata.org/wiki/Q6314146","display_name":"Engineering management","level":1,"score":0.25769999623298645},{"id":"https://openalex.org/C26517878","wikidata":"https://www.wikidata.org/wiki/Q228039","display_name":"Key (lock)","level":2,"score":0.25619998574256897},{"id":"https://openalex.org/C20136886","wikidata":"https://www.wikidata.org/wiki/Q749647","display_name":"Interoperability","level":2,"score":0.2513999938964844}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.18609/cgti.2025.053","doi":"https://doi.org/10.18609/cgti.2025.053","is_oa":true,"landing_page_url":"https://doi.org/10.18609/cgti.2025.053","pdf_url":null,"source":{"id":"https://openalex.org/S4210198480","display_name":"Cell and Gene Therapy Insights","issn_l":"2059-7800","issn":["2059-7800","2397-0545"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell and Gene Therapy Insights","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.18609/cgti.2025.053","doi":"https://doi.org/10.18609/cgti.2025.053","is_oa":true,"landing_page_url":"https://doi.org/10.18609/cgti.2025.053","pdf_url":null,"source":{"id":"https://openalex.org/S4210198480","display_name":"Cell and Gene Therapy Insights","issn_l":"2059-7800","issn":["2059-7800","2397-0545"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell and Gene Therapy Insights","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.6773999929428101,"display_name":"Industry, innovation and infrastructure","id":"https://metadata.un.org/sdg/9"}],"sustainable_development_goals_aurora":[{"score":0.5078006982803345,"display_name":"Industry, innovation and infrastructure","id":"https://metadata.un.org/sdg/9"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Despite":[0],"several":[1],"cell":[2,48],"therapy":[3,51],"approvals,":[4],"existing":[5],"manufacturing":[6],"capacity":[7],"is":[8,16],"inadequate":[9],"to":[10,18,28],"meet":[11],"high":[12],"patient":[13,26],"demand.":[14],"Automation":[15],"poised":[17],"play":[19],"a":[20],"crucial":[21],"role":[22],"in":[23],"enhancing":[24],"global":[25],"access":[27],"these":[29],"treatments.":[30],"This":[31],"article":[32],"delves":[33],"into":[34],"the":[35,46,57],"advanced":[36],"technologies":[37],"and":[38,49,59],"automation":[39],"strategies":[40],"that":[41],"are":[42],"essential":[43],"for":[44],"navigating":[45],"evolving":[47],"gene":[50],"landscape,":[52],"featuring":[53],"insights":[54],"from":[55],"both":[56],"biopharma":[58],"tool":[60],"provider":[61],"sectors.":[62]},"counts_by_year":[],"updated_date":"2026-09-09T07:26:56.047234","created_date":"2025-12-15T00:00:00"}